CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Conditions: Advanced Renal Cell Carcinoma (All Subtypes); Metastatic Renal Cell Carcinoma (All Subtypes) Intervention: Other: Documentation Sponsor: IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials